APVO vs UNP · $9.9M cap vs P/E 21, rev $6.86B
Aptevo Therapeutics Inc (APVO) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
APVO does not have a complete income-statement cache yet.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
APVO currently screens at market cap $9.9M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the APVO and UNP stock pages for the full models.
Not investment advice.